Bevacizumab-Induced Alterations in Vascular Permeability and Drug Delivery: A Novel Approach to Augment Regional Chemotherapy for In-Transit Melanoma

PURPOSE: To investigate whether the systemically administered anti-VEGF monoclonal antibody bevacizumab could improve regional chemotherapy treatment of advanced extremity melanoma by enhancing delivery and tumor uptake of regionally infused melphalan (LPAM). EXPERIMENTAL DESIGN: After treatment wit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Turley, Ryan S., Fontanella, Andrew N., Padussis, James C., Toshimitsu, Hiroaki, Tokuhisa, Yoshihiro, Cho, Eugenia H., Hanna, Gabi, Beasley, Georgia M., Augustine, Christina K., Dewhirst, Mark W., Tyler, Douglas S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3618183/
https://ncbi.nlm.nih.gov/pubmed/22496203
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-11-3000
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados